ANAPTYSBIO, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Anaptysbio, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Anaptysbio, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $151M, a 29.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $151M +$34.8M +29.9% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $117M +$30.4M +35.2% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $86.2M +$4.87M +5.99% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $81.3M +$6.85M +9.2% Dec 31, 2020 10-K 2022-03-07
Q4 2019 $74.5M +$26.9M +56.5% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $47.6M +$23.8M +99.9% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $23.8M +$4.52M +23.4% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $19.3M Dec 31, 2016 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.